Ausgabe 11/2015
Inhalt (18 Artikel)
Fluorescent radiocolloids: are hybrid tracers the future for lymphatic mapping?
Sergi Vidal-Sicart, Fijs W. B. van Leeuwen, Nynke S. van den Berg, Renato A. Valdés Olmos
Evaluation of a radioactive and fluorescent hybrid tracer for sentinel lymph node biopsy in head and neck malignancies: prospective randomized clinical trial to compare ICG-99mTc-nanocolloid hybrid tracer versus 99mTc-nanocolloid
Ingo Stoffels, Julia Leyh, Thorsten Pöppel, Dirk Schadendorf, Joachim Klode
First-in-human evaluation of a hybrid modality that allows combined radio- and (near-infrared) fluorescence tracing during surgery
Nynke S. van den Berg, Hervé Simon, Gijs H. Kleinjan, Thijs Engelen, Anton Bunschoten, Mick M. Welling, Bernard M. Tijink, Simon Horenblas, Jacques Chambron, Fijs W. B. van Leeuwen
Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?
Laura Evangelista, Anna Rita Cervino, Cristina Ghiotto, Tania Saibene, Silvia Michieletto, Bozza Fernando, Enrico Orvieto, Valentina Guarneri, Pierfranco Conte
Diagnostic accuracy of 18F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T
Heinrich F. Magometschnigg, Pascal A. Baltzer, Barbara Fueger, Thomas H. Helbich, Georgios Karanikas, Peter Dubsky, Margaretha Rudas, Michael Weber, Katja Pinker
Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype
Brittany Z. Dashevsky, Debra A. Goldman, Molly Parsons, Mithat Gönen, Adriana D. Corben, Maxine S. Jochelson, Clifford A. Hudis, Monica Morrow, Gary A. Ulaner
Positron emission tomography of tumour [18F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy
Michel van Kruchten, Andor W. J. M. Glaudemans, Erik F. J. de Vries, Carolien P. Schröder, Elisabeth G. E. de Vries, Geke A. P. Hospers
Do clinical, histological or immunohistochemical primary tumour characteristics translate into different 18F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?
David Groheux, Mohamed Majdoub, Florent Tixier, Catherine Cheze Le Rest, Antoine Martineau, Pascal Merlet, Marc Espié, Anne de Roquancourt, Elif Hindié, Mathieu Hatt, Dimitris Visvikis
iROLL: does 3-D radioguided occult lesion localization improve surgical management in early-stage breast cancer?
Christina Bluemel, Andreas Cramer, Christoph Grossmann, Georg W. Kajdi, Uwe Malzahn, Nora Lamp, Heinz-Jakob Langen, Jan Schmid, Andreas K. Buck, Hanns-Jörg Grimminger, Ken Herrmann
PET-based compartmental modeling of 124I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer
Pat Zanzonico, Jorge A. Carrasquillo, Neeta Pandit-Taskar, Joseph A. O’Donoghue, John L. Humm, Peter Smith-Jones, Shutian Ruan, Chaitanya Divgi, Andrew M. Scott, Nancy E. Kemeny, Yuman Fong, Douglas Wong, David Scheinberg, Gerd Ritter, Achem Jungbluth, Lloyd J. Old, Steven M. Larson
PET imaging of DNA damage using 89Zr-labelled anti-γH2AX-TAT immunoconjugates
James C. Knight, Caitríona Topping, Michael Mosley, Veerle Kersemans, Nadia Falzone, José M. Fernández-Varea, Bart Cornelissen
Radioembolization of hepatocarcinoma with 90Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology
C. Chiesa, M. Mira, M. Maccauro, C. Spreafico, R. Romito, C. Morosi, T. Camerini, M. Carrara, S. Pellizzari, A. Negri, G. Aliberti, C. Sposito, S. Bhoori, A. Facciorusso, E. Civelli, R. Lanocita, B. Padovano, M. Migliorisi, M. C. De Nile, E. Seregni, A. Marchianò, F. Crippa, V. Mazzaferro
DNA damage in blood lymphocytes in patients after 177Lu peptide receptor radionuclide therapy
Uta Eberlein, Carina Nowak, Christina Bluemel, Andreas Konrad Buck, Rudolf Alexander Werner, Harry Scherthan, Michael Lassmann
EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma
Christina Bluemel, Ken Herrmann, Francesco Giammarile, Omgo E. Nieweg, Julien Dubreuil, Alessandro Testori, Riccardo A. Audisio, Odysseas Zoras, Michael Lassmann, Annette H. Chakera, Roger Uren, Sotirios Chondrogiannis, Patrick M. Colletti, Domenico Rubello
18F-NaF PET/CT: EANM procedure guidelines for bone imaging
M. Beheshti, F. M. Mottaghy, F. Payche, F. F. F. Behrendt, T. Van den Wyngaert, I. Fogelman, K. Strobel, M. Celli, S. Fanti, F. Giammarile, B. Krause, W. Langsteger
Assessment of amyloid deposits by 18F-florbetapir positron emission tomography
Fernando Martínez-Valle, Mercedes Gironella, Mar Riveiro-Barciela, Carles Lorenzo-Bosquet
Erratum to: First-in-human evaluation of a hybrid modality that allows combined radio- and (near-infrared) fluorescence tracing during surgery
Nynke S. van den Berg, Hervé Simon, Gijs H. Kleinjan, Thijs Engelen, Anton Bunschoten, Mick M. Welling, Bernard M. Tijink, Simon Horenblas, Jacques Chambron, Fijs W. B. van Leeuwen